Front-Line Treatment with Second-Generation Tyrosine Kinase Inhibitors Following By Allo-Transplantation Benefits Patients with Better Survival Inph-Positive Acute Lymphoblastic Leukemia

被引：0
|
作者：
Yu, Pan
Chen, Fang
Xu, Dan
Yin, Changxin
Liu, Qifa
Sun, Jing
Fan, Zhiping
Wang, Qiang
Liu Xiaoli
Jiang, Qianli
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4522
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Milojkovic, Dragana
    Nicholson, Emma
    Apperley, Jane F.
    Holyoake, Tessa L.
    Shepherd, Pat
    Drummond, Mark W.
    Szydlo, Richard
    Bua, Marco
    Foroni, Letizia
    Reid, Alistair
    Khorashad, Jamshid S.
    de Lavallade, Hugues
    Rezvani, Katy
    Paliompeis, Christos
    Goldman, John M.
    Marin, David
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 224 - 231
  • [12] Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
    Breccia, M.
    Alimena, G.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (04) : 391 - 401
  • [13] Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib
    Breccia, Massimo
    Palandri, Francesca
    Iori, Anna Paola
    Colaci, Elisabetta
    Latagliata, Roberto
    Castagnetti, Fausto
    Torelli, Giovanni Fernando
    Usai, Sara
    Valle, Veronica
    Martinelli, Giovanni
    Rosti, Gianantonio
    Foa, Robin
    Baccarani, Michele
    Alimena, Giuliana
    LEUKEMIA RESEARCH, 2010, 34 (02) : 143 - 147
  • [14] Second-Generation Tyrosine Kinase Inhibitors Combined With Stem Cell Transplantation in Patients With Imatinib-Refractory Chronic Myeloid Leukemia
    Zhao, Yanmin
    Luo, Yi
    Shi, Jimin
    Cai, Zhen
    Huang, He
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (06): : 439 - 445
  • [15] Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed
    Ibrahim, Amr R.
    Clark, Richard E.
    Holyoake, Tessa L.
    Byrne, Jenny
    Shepherd, Pat
    Apperley, Jane F.
    Milojkovic, Dragana
    Szydlo, Richard
    Goldman, John
    Marin, David
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (12): : 1779 - 1782
  • [16] EFFICACY AND CLINICAL OUTCOME OF PHILADELPHIA (PH) POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS TREATED WITH SECOND GENERATION TYROSINE KINASE INHIBITORS (TKIS): THE BOLOGNA EXPERIENCE
    Papayannidis, C.
    Iacobucci, I.
    Soverini, S.
    Paolini, S.
    Clissa, C.
    Parisi, S.
    Abbenante, M. C.
    Colarossi, S.
    Gnani, A.
    Lonetti, A.
    Ferrari, A.
    Testoni, N.
    Amabile, M.
    Ottaviani, E.
    Curti, A.
    Guadagnuolo, V.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 257 - 257
  • [17] Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience
    Papayannidis, Cristina
    Lacobucci, Ilaria
    Soverini, Simona
    Colarossi, Sabrina
    Gnani, Alessandra
    Lonetti, Annalisa
    Ferrari, Anna
    Testoni, Nicoletta
    Amabile, Marilina
    Ottaviani, Emanuela
    Abbenante, Maria Chiara
    Curti, Antonio
    Paolini, Stefania
    Lama, Barbara
    Clissa, Cristina
    Parisi, Sarah
    Guadagnuolo, Viviana
    Baccarani, Michele
    Martinelli, Giovanni
    CANCER RESEARCH, 2010, 70
  • [18] Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
    Ottmann, Oliver G.
    Wassmann, Barbara
    Pfeifer, Heike
    Giagounidis, Aristoteles
    Stelljes, Matthias
    Duehrsen, Ulrich
    Schmalzing, Marc
    Wunderle, Lydia
    Binckebanck, Anja
    Hoelzer, Dieter
    CANCER, 2007, 109 (10) : 2068 - 2076
  • [19] Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience.
    Papayannidis, Cristina
    Iacobucci, Ilaria
    Soverini, Simona
    Colarossi, Sabrina
    Gnani, Alessandra
    Lonetti, Annalisa
    Baldazzi, Carmen
    Testoni, Nicoletta
    Amabile, Marilina
    Ottaviani, Emanuela
    Abbenante, Maria Chiara
    Curti, Antonio
    Paolini, Stefania
    Lama, Barbara
    Castagnetti, Fausto
    Poerio, Angela
    Clissa, Cristina
    Parisi, Sarah
    Polverelli, Nicola
    Guadagnuolo, Viviana
    Piccaluga, Pier Paolo
    Rosti, Gianantonio
    Baccarani, Michele
    Martinelli, Giovanni
    BLOOD, 2009, 114 (22) : 800 - 800
  • [20] Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors
    Breccia, Massimo
    Stagno, Fabio
    Gozzini, Antonella
    Abruzzese, Elisabetta
    Latagliata, Roberto
    Rossi, Antonella Russo
    Sora, Federica
    Porrini, Raffaele
    Vigneri, Paolo
    Trawinska, Malgorzata
    Montefusco, Enrico
    Sica, Simona
    Specchia, Giorgina
    Santini, Valeria
    Alimena, Giuliana
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (06) : 523 - 525
12345